Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
07/2008
07/10/2008US20080167462 2-substituted phenyl-5, 7-dehydrocarbyl-3, 7-dihydropyrrolo [2, 3-d] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof
07/10/2008US20080167368 4-{4-[3-(2-fluoro-5-trifluoromethylphenyl)ureido]phenyl}-1H-pyrrole-3-carboxamide; anticarcinogenic agents; FAK, KDR and Tie2 kinase inhibitors
07/10/2008US20080167366 Use of 2-oxo-1-pyrrolidine derivatives for the preparation of a drug
07/10/2008US20080167361 Piperazinyl-substituted quinolinone compounds ;to treat nervous system diseases, neurodegenerative diseases; gastrointestinal tract disorders; cognition enhancers; 3-[4-(3-Ethylsulfanyl-benzenesulfonyl)-2-methoxy-phenyl]-pyrrolidine and 5-(3-Ethylsulfanyl-benzenesulfonyl)-2-pyrrolidin-3-yl-phenol
07/10/2008US20080167318 Pharmaceutically active pyrrolidine derivatives
07/10/2008US20080167306 Novel Heteroaryl Derivative
07/10/2008US20080167288 Substituted cyclic hydroxamates as lnhibitors of matrix metalloproteinases
07/09/2008EP1940813A1 Heterocyclic amide derivatives useful as microbiocides
07/09/2008EP1940805A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
07/09/2008EP1940782A1 N-phenyl phenylacetamide non-nucleoside reverse transcriptase inihibitors
07/09/2008EP1940390A2 Antibacterial pyrrols
07/09/2008EP1940387A1 Process for the stereoselective preparation of (-)-halofenate and intermediates thereof
07/09/2008EP1720825B1 Anthranilic acid derivatives, methods for their preparation and use as dhodh inhibitors
07/09/2008EP1673084B1 1-2' (1,4'-biperidin-1'-yl)-1-(phenyl)-ethylcyclohexanol derivatives as monoamine reuptake modulators for the treatment of vasomotor symptoms
07/09/2008CN101218240A Process for preparing bicyclic compounds
07/09/2008CN101218239A Process for preparing bicyclic compounds
07/09/2008CN101215285A Polyhydroxy substituted octahydroindolizidine and synthesis method thereof
07/09/2008CN101215255A Method for preparing N-(2-methylphenyl)maleimide
07/09/2008CN101215254A Method for purifying N-(3-methylphenyl)maleimide
07/09/2008CN101215253A Crystalline forms of atorvastatin
07/09/2008CN101215252A Method for preparing N-Boc or N-Cbz derivatives of chiral alpha,alpha'-disubstituted pyrrolidines containing olefinic bond and acetylene bond
07/09/2008CN100400509C Pyrrolidone derivatives as MAOB inhibitors
07/09/2008CN100400487C Glucocorticoid receptor modulators
07/08/2008US7396851 Heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin A for the treatment of β-thalassaemia
07/08/2008US7396846 Growth hormone secretagogues
07/08/2008US7396844 3-(4-amidinobenzoylamino)-4-[5-amidino-2-(2-carboxy-2-oxoethyl)phenoxy]butanoic acid; anticoagulant; blood coagulation factor X and thrombin inhibitor; cerebral infarction, thrombosis, embolism, transient ischemic attack (TIA) and subarachnoidal hemorrhage (vasospasm); ischemic heart diseases
07/08/2008US7396828 PI-3 kinase inhibitor prodrugs
07/03/2008WO2008079266A2 Synthesis of pyrrolidine compounds
07/03/2008WO2008078762A1 Novel n-(2-aminophenyl)benzamide derivative having an urea structure
07/03/2008WO2008078341A2 Stable pharmaceutical formulations of atorvastatin magnesium salt
07/03/2008WO2008077897A1 New products for the treatment of the iron chlorosis
07/03/2008WO2007123686A3 Dpp inhibitors and uses thereof
07/03/2008WO2007107276A3 Process for preparing c7 intermediates and their use in the preparation of n-substituted pyrrole derivatives
07/03/2008US20080161577 Muscarinic receptor antagonists; longer duration of action; side effect reduction; high potency; chronic obstructive pulmonary disease; asthma; inhalation; 2-[(S)-1-(8-Methylaminooctyl)pyrrolidin-3-yl]-2,2-diphenylacetamide
07/03/2008US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome
07/03/2008US20080161310 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes
07/03/2008US20080161306 Pyrrole Derivatives as Dna Gyrase and Topoisomerase Inhibitors
07/03/2008US20080161281 Amino-Substituted Tricyclic Derivatives and Methods of Use
07/03/2008US20080160017 Cross-Linked Antibodies
07/03/2008CA2674548A1 Novel n-(2-aminophenyl) benzamide derivative having urea structure
07/03/2008CA2673466A1 Substituted tetracycline compounds
07/03/2008CA2672727A1 Sphingosine-1-phosphate receptor agonist and antagonist compounds
07/02/2008EP1939625A2 Methods for ligand discovery
07/02/2008EP1939175A1 Sulfonamide derivative having pgd2 receptor antagonistic activity
07/02/2008EP1939157A1 New products for the treatment of the iron chlorosis
07/02/2008EP1937664A1 Hydrazide compound and pesticidal use of the same
07/02/2008EP1937637A1 New n-alkyl-heterocyclyl carboxamide derivatives
07/02/2008EP1937634A1 Cathepsin cysteine protease inhibitors
07/02/2008EP1937632A1 Novel compounds
07/02/2008EP1937252A2 Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration
07/02/2008EP1937242A2 Methods and compositions for the treatment of neuropsychiatric and addictive disorders
07/02/2008EP1830841B1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
07/02/2008EP1729773B1 8-hydroxy-5- [(-hydroxy-2- [[ (1r)-2-(4-methoxyphenyl)-1-methylethyl] amino ][ethyl -2(1h)-quinolinone monohydrochloride in crystalline form and the process for its preparation
07/02/2008EP1648858B1 Method for production of alpha, beta-unsaturated amide compounds
07/02/2008EP1646626B1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators
07/02/2008EP1646625B1 Pyrrole-2, 5-dithione derivatives as liver x receptor modulators
07/02/2008EP1633702B1 Protease inhibitors
07/02/2008EP1496838A4 Substituted amides
07/02/2008EP1487791B1 A novel antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1h-pyrrol-2-yl)- methylethyl pentanoate
07/02/2008CN101213171A New crystalline atorvastatin hemicalcium salt polymorph form
07/02/2008CN101209987A Thermosetting resin composition containing maleimide and/or vinyl compound
07/02/2008CN100398517C substituted pyrrolidone synthesized ion liquid and its synthesis method
07/01/2008US7393873 Arylsulfonamide derivatives
06/2008
06/26/2008WO2008077035A2 Processes for the preparation of levetiracetam
06/26/2008WO2008076754A2 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
06/26/2008WO2008075353A1 Sulfonamide derivatives with therapeutic indications
06/26/2008WO2008075165A1 Novel process for the synthesis of [r-(r*, r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid or a pharmaceutically acceptable salt thereof
06/26/2008WO2008074703A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
06/26/2008WO2008014311A3 Inhibitors of undecaprenyl pyrophosphate synthase
06/26/2008WO2008002820A3 Substituted benzyl amine compounds
06/26/2008US20080153896 Polymorphic Forms of an HMG-CoA Reductase Inhibitor and Uses Thereof
06/26/2008US20080153892 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease
06/26/2008US20080153836 1H-Quinazoline-2,4-Diones
06/26/2008US20080153826 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder
06/26/2008US20080153821 Nitrogen-containing 5-membered ring compound
06/26/2008US20080152619 Hepatitis C virus inhibitors
06/26/2008US20080152588 Metal Chelators and Methods of Their Use
06/26/2008CA2695613A1 Sulfonamide derivatives with therapeutic indications
06/26/2008CA2672271A1 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
06/26/2008CA2671378A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
06/25/2008EP1935881A1 Aryl-substituted nitrogen-containing heterocyclic compound
06/25/2008EP1935879A1 Substituted cycloalkene derivative
06/25/2008EP1935869A1 Retinoids for the treatment of emphysema
06/25/2008EP1934177A1 Prolinamide derivatives as sodium channel modulators
06/25/2008EP1934176A1 Quaternary alpha-aminocarboxamide derivatives as modulators of voltage-gated sodium channels
06/25/2008EP1193253B1 Process for producing optically active azetidine-2-carboxylic acids
06/25/2008EP0986382B1 Raf kinase inhibitors
06/25/2008CN101208334A Novel cyclic amines
06/25/2008CN101208300A Derivatives of 4,5-diarylpyrrole, preparation method thereof and use of same in therapeutics
06/25/2008CN101205209A Method for refining atorvastatin intermediate
06/25/2008CN100396756C Material for light-oriented film, light-oriented film and its manufacture method
06/25/2008CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
06/25/2008CN100396668C Non-imidazole aryloxypiperidines
06/25/2008CN100396667C Unsaturated five heterocycle compound for up-regulating bone formation protein BMP-2 expression activity
06/25/2008CN100396666C (4S)-1-tert butoxy carbonyl-4-amino-L-ethyl prolinate and its synthesis technology
06/25/2008CN100396665C Pyrrolidine derivative, preparation method thereof and pharmaceutical composition containing the compound
06/24/2008US7390910 Antitumor, anticancer agents; for drug resistant tumors, cancers
06/24/2008US7390890 1,4-Dideoxy-1-C-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives or salts; parasite purine nucleoside, -hydrolase, -phosphorylase and/or phosphoribosyl transferase inhibitors; antiprotozoa, anticarcinogenic, antiinflammatory, and immunosuppressant agents; autoimmune diseases
06/24/2008US7390835 Aralkyl amines as cannabinoid receptor modulators
06/24/2008US7390830 MIP-1 alpha and/or MCP-1 antagonists; rheumatoid arthritis; nephritis; multiple sclerosis; nephropathy